B5.048 - GI Pharmacology Flashcards
most common secretory disorders
acid peptic disease and GERD
lifetime prevalence of peptic ulcer disease and GERD
10%
50%
drug classes for GERD and peptic ulcer disease
PPIs H2 antagonists antacids mucosal protective agents antimicrobial agents
what are benzimidazoles
PPI
compounds irreversibly inhibit parietal cell proton pump H+K+ATPase
activation of PPIs
requires an acidic environment (should be taken with food)
PPIs are unstable at low pH, degradation prevented by enteric coating of tablets
how do PPIs retain their efficacy with chronic use
all are prodrugs that are inactive at neutral pH
parietal intracellular canaliculi are upstream from PP target at luminal membrane
what are the PPIs
prazole esomeprazole omeprazole lansoprazole dexlansoprazole pantoprazole rabeprazole
what are currently the most effective drugs for suppressing gastric acid secretion
PPIs because of gastric response to all stimuli inhibited
dosing of PPIs
single daily dose
doest affect pepsin or gastric motility